We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+22.5%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$664M
AUM Growth
-$183M
(-22%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-32.96%
Top 10 Holdings %
Top 10 Hldgs %
55.23%
Holding
79
New
18
Increased
15
Reduced
15
Closed
24
Avg Time Held Equity + Options
3.1
quarters
Top 10 Avg Time Held Equity + Options
1.6
quarters
Top 20 Avg Time Held Equity + Options
1.4
quarters
Avg Time Held Equity only
3.6
quarters
Top 10 Avg Time Held Equity only
1.7
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ally Financial
ALLY
|
+$22.3M |
| 2 |
Crocs
CROX
|
+$15.1M |
| 3 |
Vertiv
VRT
|
+$14.1M |
| 4 |
Hello Group
MOMO
|
+$12.1M |
| 5 |
Fastenal
FAST
|
+$9.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$30.6M |
| 2 |
Aramark
ARMK
|
+$26.4M |
| 3 |
Alibaba
BABA
|
+$22.5M |
| 4 |
argenx
ARGX
|
+$21M |
| 5 |
Motorola Solutions
MSI
|
+$20.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.33% |
| 2 | Miscellaneous | 20.1% |
| 3 | Consumer Discretionary | 13.24% |
| 4 | Technology | 8.87% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $68.5M | 10.31% |
1,257,720
+100,946
| +9% | +$5M |
2018 Q1
7 quarters
|
|
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| $64.4M | 9.7% |
200,000
-46,000
| -19% | -$14.2M |
2019 Q3
1 quarter
|
|
3
Crown Holdings
CCK
$12B
| $35.4M | 5.33% |
487,507
+96,884
| +25% | +$6.91M |
2019 Q3
1 quarter
|
|
4
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.71B
| $33.3M | 5.01% |
350,000
+190,000
| +119% | +$16.4M |
2019 Q2
2 quarters
|
|
5
Alphabet (Google) Class A
GOOGL
$4.33T
| $32.3M | 4.87% |
482,560
-31,980
| -6% | -$2.06M |
2019 Q1
3 quarters
|
|
6
Caesars Entertainment
CZR
$6.01B
| $31.6M | 4.77% |
530,401
-125,000
| -19% | -$6.19M |
2018 Q4
4 quarters
|
|
|
AERI
7
DELISTED
Aerie Pharmaceuticals
AERI
| $29.6M | 4.46% |
1,224,825
+414,337
| +51% | +$8.58M |
2019 Q3
1 quarter
|
|
8
Constellium
CSTM
$3.49B
| $27.8M | 4.19% |
2,077,925
+10,745
| +0.5% | +$148K |
2017 Q3
9 quarters
|
|
9
Microsoft
MSFT
$4.04T
| $21.9M | 3.31% |
139,167
-78,300
| -36% | -$11.5M |
2018 Q2
6 quarters
|
|
|
10
Ally Financial
ALLY
$11.4B
| $21.8M | 3.29% |
+714,040
| New | +$22.3M |
2019 Q4
0 quarters
|
|
11
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $20.4M | 3.07% |
983,924
| – | – |
2014 Q1
23 quarters
|
|
|
12
Crocs
CROX
$5.63B
| $18.1M | 2.73% |
+433,213
| New | +$15.1M |
2019 Q4
0 quarters
|
|
|
ATNX
13
DELISTED
Athenex, Inc. Common Stock
ATNX
| $17.6M | 2.65% |
57,500
+30,681
| +114% | +$8.11M |
2018 Q4
4 quarters
|
|
14
Rapid7
RPD
$871M
| $17.5M | 2.63% |
312,168
+17,699
| +6% | +$921K |
2019 Q1
3 quarters
|
|
|
15
Vertiv
VRT
$91.4B
| $14.9M | 2.24% |
+1,347,647
| New | +$14.1M |
2019 Q4
0 quarters
|
|
16
WillScot Mobile Mini Holdings
WSC
$3.13B
| $14.6M | 2.2% |
790,952
+59,652
| +8% | +$1M |
2018 Q1
7 quarters
|
|
|
MDCO
17
PUT
DELISTED
Medicines Co
MDCO
| $12.7M | 1.92% |
+150,000
| New | +$10M |
2019 Q4
0 quarters
|
|
18
Nomad Foods
NOMD
$1.6B
| $12.4M | 1.87% |
553,577
-52,342
| -9% | -$1.07M |
2016 Q1
15 quarters
|
|
19
PUT
State Street Communication Services Select Sector SPDR ETF
XLC
$23.9B
| $12.1M | 1.82% |
+225,000
| New | +$11.6M |
2019 Q4
0 quarters
|
|
20
Permian Resources
PR
$20.3B
| $11.8M | 1.77% |
+2,550,000
| New | +$9.32M |
2019 Q4
0 quarters
|
|
|
21
Hello Group
MOMO
$682M
| $11.4M | 1.71% |
+339,149
| New | +$12.1M |
2019 Q4
0 quarters
|
|
22
Union Pacific
UNP
$168B
| $10.5M | 1.58% |
58,008
-45,059
| -44% | -$7.71M |
2019 Q3
1 quarter
|
|
|
23
Fastenal
FAST
$59B
| $9.98M | 1.5% |
+540,000
| New | +$9.65M |
2019 Q4
0 quarters
|
|
24
Sol-Gel Technologies
SLGL
$224M
| $9.8M | 1.48% |
57,138
| – | – |
2018 Q1
7 quarters
|
|
25
PTC Therapeutics
PTCT
$5B
| $9.78M | 1.47% |
203,711
+20,592
| +11% | +$875K |
2019 Q2
2 quarters
|
|
Similar funds
PHP
ACM
FM
PFGIA
PAMI
SI
ZI
RIA
Kingdon Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Kingdon Capital Management held 79 positions worth $664M, down 22% from $847M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Kingdon Capital Management withdrew a net $219M in Q4 2019, closing 24 positions and reducing 15 holdings. Its most notable exit was Marathon Petroleum, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
Against the trend, Kingdon Capital Management opened a new position in Ally Financial worth $21.8M.
- Kingdon Capital Management's largest Q4 2019 buy was Ally Financial: 714,040 shares worth $21.8M.
- Kingdon Capital Management added most to Aerie Pharmaceuticals in Q4 2019, an estimated $8.58M increase.
- Kingdon Capital Management's biggest Q4 2019 reduction was Regeneron Pharmaceuticals, cutting an estimated $20.4M.
- Kingdon Capital Management fully exited Marathon Petroleum in Q4 2019, selling an estimated $30.6M.
- Kingdon Capital Management's ten largest holdings make up 55% of its $664M portfolio in Q4 2019.
- Kingdon Capital Management opened 18 new positions and closed 24 in Q4 2019.
- Kingdon Capital Management's portfolio value fell 22% quarter-over-quarter to $664M.
Based on Kingdon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.